Patent ID: 6130217
Filing Date: 2000-10-10
Classification: C07D,Y02A

Abstract:
A compound slected from the following compounds, or a pharmaceutically-acceptable salt thereof:1-[4-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-3-(3-m ethyl-3H-benzoimidazol-4-yloxy)-propan-2-ol,1-[4-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-3-(3-m ethyl-3H-benzotriazol-4-yloxy)-propan-2-ol,1-(benzothiazol-7-yloxy)-3-[4-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-y l)-piperazin-1-yl)-propan-2-ol,1-[4-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-3-(2-m ethyl-benzo-thiazol-7-yloxy)-propan-2-ol,1-[4-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-3-(2-d imethyl-amino-benzothiazol-7-yloxy)-propan-2-ol,7-{3-[4-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-2-h ydroxy-propoxy}-benzothiazol-2-carboxylic acid amide, and1-[4-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-3-(2-p yridin-3-yl-benzothiazol-7-yloxy)-propan-2-ol.